MaxCyte and ScaleReady have partnered for the G-Rex Grant Program, which aims to accelerate cell and gene therapy development. The program offers resources, tools, and expertise to recipients. MaxCyte’s electroporation technology and ScaleReady’s manufacturing solutions are key components of the program. The goal is to reduce barriers to entry for CGT companies and expedite the development of life-saving therapies.
MaxCyte and ScaleReady have partnered for the G-Rex Grant Program, which aims to accelerate cell and gene therapy development. The program offers resources, tools, and expertise to recipients. MaxCyte’s electroporation technology and ScaleReady’s manufacturing solutions are key components of the program. The goal is to reduce barriers to entry for CGT companies and expedite the development of life-saving therapies.
